Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
SCHIFF ANDREW N
Director at Aclaris Therapeutics. Filing since 16 Aug 2017.
CIK 0001172252
Company
Date
Role
Action
Shares
Amount
Of holding
ACRS
Aclaris Therapeutics, Inc.
14 Nov 2022
Director
Sold, plan not stated
1,371
$23.42K
0.3%
ACRS
Aclaris Therapeutics, Inc.
11 Nov 2022
Director
Sold, plan not stated
41,160
$702.18K
8.6%
ACRS
Aclaris Therapeutics, Inc.
10 Nov 2022
Director
Sold, plan not stated
11,395
$194.00K
2.3%
ACRS
Aclaris Therapeutics, Inc.
26 Oct 2022
Director
Sold, plan not stated
14,540
$247.25K
2.9%
ACRS
Aclaris Therapeutics, Inc.
25 Oct 2022
Director
Sold, plan not stated
12,018
$204.52K
2.3%
ACRS
Aclaris Therapeutics, Inc.
24 Oct 2022
Director
Sold, plan not stated
14,616
$248.59K
2.8%
ACRS
Aclaris Therapeutics, Inc.
18 Oct 2022
Director
Sold, plan not stated
32,093
$542.02K
5.7%
ACRS
Aclaris Therapeutics, Inc.
17 Oct 2022
Director
Sold, plan not stated
19,944
$320.09K
3.4%
ACRS
Aclaris Therapeutics, Inc.
7 Oct 2022
Director
Sold, plan not stated
7,324
$118.35K
1.2%
ACRS
Aclaris Therapeutics, Inc.
6 Oct 2022
Director
Sold, plan not stated
37,839
$625.74K
6.0%
ACRS
Aclaris Therapeutics, Inc.
4 Oct 2022
Director
Sold, plan not stated
7,700
$123.26K
1.2%
ACRS
Aclaris Therapeutics, Inc.
17 Jun 2022
Director
Sold, plan not stated
19,565
$296.27K
100%
ACRS
Aclaris Therapeutics, Inc.
16 Aug 2017
Director
Bought
108,601
$2.50M
20.7%
13 decisions on file.
